Tolerability and safety aspects of mirtazapine
- 7 June 2002
- journal article
- review article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 17 (S1), S37-S41
- https://doi.org/10.1002/hup.388
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Mirtazapine Versus Venlafaxine in Hospitalized Severely Depressed Patients With Melancholic FeaturesJournal of Clinical Psychopharmacology, 2001
- Mirtazapine compared with paroxetine in major depression.The Journal of Clinical Psychiatry, 2000
- Mirtazapine substitution in SSRI-induced sexual dysfunction.The Journal of Clinical Psychiatry, 2000
- Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.The Journal of Clinical Psychiatry, 2000
- Sexual functioning in depressed outpatients taking mirtazapineDepression and Anxiety, 1999
- The effects of mirtazapine on central noradrenergic and serotonergic neurotransmissionInternational Clinical Psychopharmacology, 1995
- Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapineInternational Clinical Psychopharmacology, 1995
- The α2-selective adrenoceptor antagonist org 3770 (mirtazapine, Remeron®) enhances noradrenergic and serotonergic transmissionHuman Psychopharmacology: Clinical and Experimental, 1995
- The Selective α2-Adrenoceptor Antagonist Mirtazapine (Org 3770) Enhances Noradrenergic and 5-HT1A-Mediated Serotonergic NeurotransmissionCNS Drugs, 1995
- The Effects of Mirtazapine on the Interactions between Central Noradrenergic and Serotonergic SystemsCNS Drugs, 1995